Actively Recruiting
Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults
Led by Universidad de Granada · Updated on 2026-04-13
80
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.
CONDITIONS
Official Title
Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-65 years
- Mild-to-moderate sleep disturbances
- Body mass index (BMI) between 18 and 35 kg/m²
- Not receiving active pharmacological or psychological treatment for sleep disorders
- Willingness to comply with study procedures
You will not qualify if you...
- Severe neurological, psychiatric, or cardiovascular disorders
- Diagnosed with obstructive sleep apnea and treated with CPAP
- Night shift workers
- Use of medications or supplements affecting sleep
- Recreational drug use
- Pregnancy or breastfeeding
- Uncontrolled medical conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universidad de Granada
Granada, Granada, Spain, 18016
Actively Recruiting
Research Team
L
Lucas Jurado-Fasoli, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here